Thrombosis UK | The Thrombosis Charity wishes to increase awareness of thrombosis among the public and health professionals and to raise research funds to improve patient care. Helping people who suffer from VTE, DVT, PE and clots.

Case Finding Service assists GPs with the complete management of patients with AF

Rivaroxaban Appears Safe, Effective for Pediatric Acute Venous Thromboembolism — Rivaroxaban Appears Safe, Effective for Pediatric Acute Venous Thromboembolism

According to findings from the phase 3 EINSTEIN-Jr study, treatment with rivaroxaban resulted in similar rates of recurrent venous thromboembolism (VTE) and bleeding when compared with standard anticoagulation among pediatric patients with previously diagnosed acute VTE who had started heparin therapy.

BMJ: An NHS success story that should be exported globally Prof Beverley Hunt OBE — BMJ: An NHS success story that should be exported globally Prof Beverley Hunt OBE

Venous thromboembolism is a serious healthcare problem affecting over 1 in 1000 adults worldwide annually. Epidemiological studies have shown that before the use of thromboprophylaxis in hospital, 55-60% of all venous thromboembolisms were related to hospital admission, occurring either in hospital or within 90 days after discharge.

Sex matters: Practice 5P's when treating young women with venous thromboembolism — Sex matters: Practice 5P's when treating young women with venous thromboembolism

Sex matters when it comes to venous thromboembolism (VTE). We defined 5P's - period, pill, prognosis, pregnancy, and post-thrombotic syndrome - that should be discussed with young women with VTE. Menstrual blood
loss (Period) can be aggravated by anticoagulant therapy. This seems particularly true for direct oral anticoagulants.

Thrombosis UK had a stand at the BSH 2019 ASM in Glasgow — Thrombosis UK had a stand at the BSH 2019 ASM in Glasgow

British Society for Haematology (BSH) have put together a playlist of interviews with 23 expert speaker videos on Youtube which may be of interest to Thrombosis UK members.

Percutaneous mechanical thrombectomy for acute deep vein thrombosis of the leg IPG651 — Percutaneous mechanical thrombectomy for acute deep vein thrombosis of the leg IPG651

Evidence-based recommendations on percutaneous mechanical thrombectomy for acute deep vein thrombosis of the leg in adults. This involves removing the clot through a catheter inserted into the vein.

Updated 2018 NICE guidance on venous thromboembolism – does evidence from root cause analysis of hospital‐associated thrombosis support the additional investment required? — Updated 2018 NICE guidance on venous thromboembolism – does evidence from root cause analysis of hospital‐associated thrombosis support the additional investment required?

The 2018 updated National Institute for Health and Care Excellence (NICE) guidance on venous thromboembolism (VTE) (NICE 2018)includes significant changes and extensions to the 2010 guidance on VTE risk assessment and thromboprophylaxis for hospital patients (NICE 2010).

Professor Beverley Hunt Recognized as Officer of the Most Excellence Order of the British Empire for Service to Medicine — Professor Beverley Hunt Recognized as Officer of the Most Excellence Order of the British Empire for Service to Medicine

LONDON, JUNE 7, 2019 — Thrombosis UK and the International Society on Thrombosis and Haemostasis (ISTH) welcome today’s announcement by Her Majesty the Queen that Professor Beverley Hunt
has been awarded an Officer of the Most Excellence Order of the British Empire in the Queen’s Birthday Honours List 2019. The award recognizes Hunt’s service to medicine.

Direct oral anticoagulants for the management of venous thromboembolism in patients with HIV – a single centre experience — Direct oral anticoagulants for the management of venous thromboembolism in patients with HIV – a single centre experience

Human immunodeficiency virus (HIV) infection remains one of the biggest health burdens worldwide, affecting 36.9 million people (World Health Organisation, 2017). Venous thromboembolism (VTE) has a reported incidence of 0.19–7.63% in those with HIV, representing a 2–10 fold increase compared to the general population (Bibas et al, 2011; Rasmussen et al, 2011).

NICE NG89 recommendations for extended pharmacological thromboprophylaxis – is it justified and is it cost effective: a rebuttal from the British Society for Haematology — NICE NG89 recommendations for extended pharmacological thromboprophylaxis – is it justified and is it cost effective: a rebuttal from the British Society for Haematology

We are writing to express our collective concern about the recommendation in the National Institute for Health and Care Excellence (NICE) guideline [NG89].

Page 1 of 5 Next